Working to Eradicate Gynecologic Cancers

Ximena Burbano-Levy, MD

faculty
Zilonis Health, Inc.
1475 NW 12th Ave
Suite 3500
Miami, FL
USA 33136

Papers:
142 - Scientific Plenary A cost-effectiveness analysis of four chemotherapy regimens used in the treatment of platinum-sensitive recurrent epithelial ovarian carcinoma 366 - Poster Session B Is the survival advantage gained by the addition of bevacizumab to chemotherapy for the treatment of recurrent, persistent, or advanced cervical cancer worth the additional cost? A cost-effectiveness analysis